Adaptive Biotechnologies Corp. (ADPT)
15.76
-0.20
(-1.25%)
USD |
NASDAQ |
Jan 09, 16:00
15.76
0.00 (0.00%)
Pre-Market: 20:00
Adaptive Biotechnologies Research and Development Expense (Annual): 94.33M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 4.624B |
| Zymeworks, Inc. | 134.62M |
| Cue Biopharma, Inc. | 35.93M |
| Recursion Pharmaceuticals, Inc. | 296.23M |
| Arcellx, Inc. | 157.09M |